Ceribell vs VisualDx
VisualDx lists Core (education) at $249.99 per year and Elite (clinicians) at $299.99 per year, both billed annually, and quotes groups of two to five users on request. A clinician subscribes to build a differential and compare lesion images by skin tone, and the vendor says the library holds 50,000+ clinical images. VisualDx's site states no FDA clearance, and a 2020 DermExpert FAQ says VisualDx is exempt from FDA regulation.
Ceribell is bought by a hospital under an order-based contract, with fees paid in advance on net 30 terms. Its recorder puts an EEG headband on the patient, and the delirium monitor produces a delirium-biomarker score updated every 10 seconds, the vendor says. Ceribell has 16 FDA 510(k) records. VisualDx supports a clinician's differential at the point of care, while Ceribell's recorder streams to a remote portal for review.
Decision support · Reviewed November 2, 2026
When to pick each one
Ceribell
- Order-based fees paid in advance on net 30
- Remote portal showing seizure burden and delirium trend
VisualDx
- Core (education) $249.99, Elite (clinicians) $299.99 yearly
- Differential builder with skin-tone image comparison
Score
Each row shows points earned of points available under the published rubric.
Ceribell
49of 100
VisualDx
48of 100
| Dimension | Ceribell | VisualDx | Difference |
|---|---|---|---|
| FDA clearance | 12 / 12 | 0 / 12 | +12 |
| HIPAA / SOC2 / BAA | 0 / 10 | 0 / 10 | 0 |
| EHR integrations (count) | 0 / 5.6 | 0 / 5.6 | 0 |
| Top-3 EHR coverage (Epic / Oracle / Athena) | 0 / 4.8 | 0 / 4.8 | 0 |
| Bidirectional write-back | 0 / 1.2 | 0 / 1.2 | 0 |
| Peer-reviewed papers | 14.7 / 21 | 14.7 / 21 | 0 |
| RCT / meta-analysis / systematic review | 4.5 / 9 | 9 / 9 | -4.5 |
| Funding & adoption signal | 8.4 / 12 | 8.4 / 12 | 0 |
| Pricing transparency | 1.3 / 2.5 | 2.5 / 2.5 | -1.2 |
| Years in market | 0 / 6 | 6 / 6 | -6 |
Scroll horizontally to see every column.
Pricing
Ceribell
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. Purchase terms: one-year initial term, auto-renewing yearly unless 90 days notice. |
VisualDx
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Core (education) | n/a | $249.99 | Shown as $39.99 or $20.83 per month, billed annually. Free trial length is not stated. Annual plans that auto-renew have a 30-day grace period for a full refund of the renewed fee. |
| Elite (clinicians) | n/a | $299.99 | Shown as $49.99 or $24.99 per month, billed annually. |
| Groups and Enterprise | n/a | n/a | Contact for pricing, including small groups of 2 to 5 users. |
Evidence
Ceribell
FDA decisions
K261712 (opens in new tab)510(k)2026-09-16
Ceribell EEG Analysis Software
K261101 (opens in new tab)510(k)2026-06-30
Ceribell Monitor
K260998 (opens in new tab)510(k)2026-06-24
Ceribell Neurology Review Software
K260363 (opens in new tab)510(k)2026-04-03
Ceribell Brain Monitor Headband
K254033 (opens in new tab)510(k)2026-02-09
Ceribell Instant EEG Headset
Show 11 more
K251936 (opens in new tab)510(k)2025-12-08
Ceribell Delirium Monitor System
K252070 (opens in new tab)510(k)2025-11-21
Ceribell Infant Seizure Detection Software
K251381 (opens in new tab)510(k)2025-10-31
Ceribell Instant EEG Headcap
K241589 (opens in new tab)510(k)2025-04-09
Ceribell Seizure Detection Software
K232052 (opens in new tab)510(k)2023-08-08
Ceribell Instant EEG Headband
K223504 (opens in new tab)510(k)2023-05-23
Ceribell Status Epilepticus Monitor
K223086 (opens in new tab)510(k)2023-03-22
Ceribell Instant EEG Headcap
K210805 (opens in new tab)510(k)2021-08-30
Ceribell Instant EEG Headband
K191301 (opens in new tab)510(k)2019-09-11
Ceribell Pocket EEG Device
K171459 (opens in new tab)510(k)2017-08-21
Ceribell Instant EEG Headband
K170363 (opens in new tab)510(k)2017-05-08
Ceribell Pocket EEG Device
Peer-reviewed
4 PubMed records name Ceribell.
- Automated Seizure Detection in Patients with Cardiac Arrest: A Retrospective Review of Ceribell™ Rapid-EEG Recordings. (opens in new tab)
- Point-of-Care EEG Artificial Intelligence Measure of Seizure Burden Associates With Clinical Outcome at Discharge. (opens in new tab)
- Assessing the performance of artificial intelligence in detecting electrographic status epilepticus when human experts often disagree. (opens in new tab)
VisualDx
FDA decisions
No FDA decision cited in our research as of October 20, 2026.
Peer-reviewed
4 PubMed records name VisualDx.
- Early Perspectives on Utilization of a Clinical Decision Support Tool: A Mixed-Methods Study. (opens in new tab)
- Experiences, challenges and lessons while implementing a clinical decision support system in Botswana. (opens in new tab)
- Racial disparities in skin tone representation of dermatomyositis rashes: a systematic review. (opens in new tab)
Compliance and integrations
Documented from each vendor’s own pages.
| Spec | Ceribell | VisualDx |
|---|---|---|
| Free tier | ||
| HIPAA | ||
| SOC 2 Type II | ||
| EHR integrations | Not specified | Not specified |
| Founded | n/a | 1999 |
| HQ | US | US |
Scroll horizontally to see both columns.
Common questions
Open the full decision support comparison
Differential diagnosis, treatment guidance, drug interactions, evidence-grounded Q&A. The CDS landscape ranges from the UpToDate gold standard to physician-only OpenEvidence. We compared what clinicians actually use.


